2m 2m 2m 2m 2m 2m 2m
DENALI THERAPTCS (DNLI)
NASDAQ
$21.21+$0.12 (+0.56%)
Price as of Sep 11, 2026 7:59 PM EDT- $3.4BMarket Cap
- 48.63%1-Year Change
- BiotechnologyIndustry
DENALI THERAPTCS (DNLI)
$21.21+$0.12 (+0.56%)
DNLI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.09 | ||
Change | -$0.31 (-1.45%) | ||
Open | $21.65 | ||
High | $21.79 | ||
Low | $21.05 | ||
Previous Close | $21.40 | ||
Volume | 1,239,511 | ||
30-Day Average Volume | 1,179,234 | ||
1-Week Change | -5.34% | ||
1-Month Change | -14.58% | ||
1-Year Change | 48.63% | ||
3-Year Change | -11.87% | ||
5-Year Change | -59.15% | ||
Fundamentals | |||
Shares Outstanding | 159.8M | ||
Total Assets | $1.2B | ||
Market Cap | $3.4B | ||
Enterprise Value | $3.2B | ||
Period: QTR TTM FY | |||
Revenue | $3.6M | ||
Net Income | -$127.6M | ||
Free Cash Flow | -$97.8M | ||
EBIT | -$127.6M | ||
EBITDA | -$124.0M | ||
Net Working Capital | $663.8M | ||
EPS | -$0.68 | ||
Enterprise Value/EBITDA | -26 | ||
Enterprise Value/Revenue | 879 | ||
P/B | 4 | ||
P/E | -31 | ||
PEG | -21 | ||
Price/Free Cash Flow | -34 | ||
Price/Operating Cash Flow | -35 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue